Clinical TrialsSearch results
Number of results: 279
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Multicenter study for combined therapy of prednisolone and cyclosporin in refractory nephrotic syndrome
- membranouos nephropathy and focal segmental glomerulosclerosis with primary steroid resistant nephrotic syndrome
- Project team for treatment of refractory nephrotic syndrome
- 2006-03-27
Other
- Multicenter study for combined therapy of prednisolone and mizoribine in idiopathic membranous nephropathy with refractory nephrotic syndrome
- membranous nephropathy with primary steroid resistant nephrotic syndrome
- Project team for treatment of refractory nephrotic syndrome
- 2006-03-27
Other
- Primary prevention of cerebrovascular and cardiovascular events with an oral antidiabetic agent in patients with type 2 diabetes at high risk for cerebral infarction
- Type 2 Diabetes
- PROFIT-J Study Steering Committee
- 2007-10-09
Other
- Post-marketing study of cilostazol: Study to Confirm Efficacy in Preventing Recurrent Cerebral Infarction in Comparison with Aspirin
- Patients with cerebral infarction (excluding cardiogenic cerebral embolism)
- Otsuka Pharmaceutical Co., Ltd.
- 2005-09-13
Other
- Study for the effectiveness of intensive therapy for diabetic nephropathy in unblinded, randomized intergroup comparison study.
- Diabetic Nephropathy
- Okayama University Hospital
- 2005-11-16
Completed
- Fasudil trial phase 1 study(FAS1)
- Healthy
- Okamoto Ryuji
- 2022-02-14
Completed
- Evaluation of Rivaroxaban for Isolated Calf Deep Vein Thrombosis
- isolated calf deep vein thrombosis
- Ogihara Yoshito
- 2019-04-10
Other
- Outcome Assessment using SF-36 v2 in Stroke Patient Study
- Brain infarction
- OASIS STUDY Research Group
- 2008-05-31
Other
- Phase II study of SMILE chemotherapy for stage IV or relapsed/refractory extranodal NK/T-cell lymphoma
- extranodal NK/T-cell lymphoma, nasal type
- NK-cell Tumor Study Group
- 2007-05-14
Other
- Quantification of Epstein-Barr virus DNA in patients undergoing SMILE chemotherapy for stage IV or relapsed/refractory extranodal NK/T-cell lymphoma
- untreated stage IV or relapsed/refractory NK/T-cell lymphoma
- NK-cell Tumor Study Group
- 2007-06-18